Therapy with radiolabeled somatostatin peptide analogs for metastatic neuroendocrine tumors

J Gastrointest Surg. 2006 Mar;10(3):335-6. doi: 10.1016/j.gassur.2005.08.025.

Author

David Bushnell¹

Affiliation

¹ Diagnostic Imaging Service, Iowa City VAMC, and Radiology Department, University of Iowa Hospital and Clinics, 200 Hawkins Drive, 3856 JPP, Iowa City, IA 52242, USA.

PMID: 16622984
DOI: 10.1016/j.gassur.2005.08.025

No abstract available

Publication types

Review

MeSH terms

Clinical Trials as Topic
Humans
Neoplasm Metastasis
Neuroendocrine Tumors / diagnostic imaging*
Neuroendocrine Tumors / pathology
Octreotide / analogs & derivatives*
Octreotide / therapeutic use
Pancreatic Neoplasms / diagnostic imaging*
Pancreatic Neoplasms / pathology
Radionuclide Imaging
Somatostatin / therapeutic use*
Yttrium Radioisotopes / therapeutic use

Substances

Yttrium Radioisotopes
Somatostatin
90Y-octreotide, DOTA-Tyr(3)-
Octreotide